Skip to content

Psilocybin-induced takotsubo cardiomyopathy

Wiktoria Julia Kotts, David Gamble, Dana Dawson, David E. Connor

BMJ Case Reports May 1, 2022 DOI: 10.1136/bcr-2021-245863 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report Peer reviewed
Sample size 1
Population Patient who ingested Psilocybe semilanceata
Topics Psilocybin
Keywords Cardiomyopathy Takotsubo syndrome Cardiology Hallucinogen Electroconvulsive therapy studies
Citations 10
Key findings Takotsubo cardiomyopathy can occur after ingestion of Psilocybe semilanceata, with this being the second reported case.

Abstract

We present a case of takotsubo cardiomyopathy following recreational ingestion of Psilocybe semilanceata (known as ‘magic mushrooms’). The patient presented with respiratory distress and pulmonary oedema responding to standard medical measures. Investigations included: echocardiogram, cardiac MRI and angiogram. Based on our search, we suggest this is only the second recognised case in the published literature.

Comparable studies

Other case reports and case series on psilocybin, most cited first.

Study Year Design Participants
Psilocybin Mushroom (Psilocybe semilanceata) Intoxication with Myocardial Infarction 18-year-old man 1998 Case study n = 1
Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF) Person with leg amputation and phantom-limb pain 2018 Case study n = 1
Hallucinogen persisting perception disorder after psilocybin consumption: a case study 18-year-old man with HPPD after mixed psilocybin and cannabis intoxication 2005 Case study n = 1
Microdosing psilocybin for chronic pain: a case series Individuals with chronic neuropathic pain 2022 Case series n = 3
Psilocybin and Obsessive Compulsive Disorder Individual with Obsessive Compulsive Disorder 2014 Case study n = 1

Citations in the library

Explore topics